Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021

In Federal, Other Industry, Pharma Industry, RegulatoryDecember 17, 202079 Views

Drug manufacturer vendor Kalderos says it expects several companies to begin using its 340B Pay platform during the next three months.

Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021

Drug manufacturer reimbursement vendor Kalderos expects “a number of manufacturers” will begin using its 340B Pay software platform during the first quarter of 2021, the company told 340B Report last night. “We are fielding a high level of interest from drug manufacturers of all sizes,” the company said.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021

Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga

Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021

Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga

Site Footer